The Washington DC VA Medical Center is conducting a prospective biospecimen and clinical data repository study focused on advanced prostate cancer in Veterans. The research aims to generate reproducible proteomic data from longitudinal plasma specimens to link circulating changes with clinical outcomes. This work will inform future biomarker validation and precision oncology strategies. No specific timelines, budget amounts, or performance location beyond the Washington DC VA Medical Center are mentioned in the description.